Biomarkers for coronary heart disease clinical risk prediction: A critical appraisal

Preventive Cardiology

Volumn 13, Issue 4, 2010, Pages 160-165

  Wilkins, John T ^a   Lloyd Jones, Donald M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CARDIOVASCULAR RISK; DISEASE MARKER; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL LITERATURE; MEDICAL SOCIETY; PRIORITY JOURNAL; SCREENING TEST;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; GENOTYPE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; TROPONIN;

EID: 77957159007     PISSN: 1520037X     EISSN: 17517141     Source Type: Journal    
DOI: 10.1111/j.1751-7141.2010.00081.x     Document Type: Article

References (28)

1. D'Agostino S, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286(2):180-187.
2. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
3. Cavanaugh-Hussey MW, Berry JD, Lloyd-Jones DM. Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool. Prev Med 2008, 47:619-623.
4. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007, 297(6):611-619.
5. Ridker PM. Evaluating novel cardiovascular risk factors: can we better predict heart attacks? Ann Inter Med 1999, 130(11):933.
6. Greenland P, Knoll MD, Stamler J. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003, 290(7):891-897.
7. Khot UN, Bajzer CT, Sapp SK. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003, 290(7):898-904.
8. Wilson PWF. Challenges to improve coronary heart disease risk assessment. JAMA 2009, 302(21):2369-2370.
9. Pepe MS, Janes H, Longton G. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004, 159:882-890.
10. Wilson PW, Nam BH, Pencina M. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med 2005, 165(21):2473-2478.
11. Pencina MJ, D'Agostino RB, D'Agostino RB. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27(2):157-172.
12. Shah T, Casas JP, Cooper JA. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol 2009, 38(1):217-231.
13. Kim HC, Greenland P, Rossouw JE. Multimarker prediction of coronary heart disease risk: the women's health initiative. J Am Coll Cardiol 2010, 55(19):2080-2091.
14. Ridker PM, Cushman M, Stampfer MJ. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336(14):973-979.
15. Buckley DI, Fu R, Freeman M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2009, 151:483-495.
16. Cook N, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models in women. Ann Intern Med 2006, 145:21-29.
17. van der Meer IM, de Maat MP, Kiliaan AJ. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch Intern Med 2003, 163(11):1323-1328.
18. Cushman M, Arnold AM, Psaty BM. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study. Circulation 2005, 112(1):25-31.
19. Folsom AR, Chambless LE, Ballantyne CM. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med 2006, 166(13):1368-1373.
20. Wang TJ, Gona P, Larson MG. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006, 355(25):2631-2639.
21. Shlipak MG, Fried LF, Cushman M. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005, 293(14):1737-1745.
22. Morrison AC, Bare LA, Chambless LE. Prediction of coronary heart disease risk using a genetic risk score: the atherosclerosis risk in communities study. Am J Epidemiol 2007, 166(1):28-35.
23. Paynter NP, Chasman Di, Pare G. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA 2010, 303(7):631-637.
24. Polonsky TS, McClelland RL, Jorgensen NW. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010, 303(16):1610-1616.
25. Nambi V, Chambless L, Folsom AR. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 2010, 55(15):1600-1607.
26. Stamler J, Stamler R, Neaton JD. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999, 282(21):2012-2018.
27. Lloyd-Jones DM, Leip EP, Larson MG. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006, 113:791-798.
28. Daviglus ML, Liu K, Pirzada A. Favorable cardiovascular risk profile in middle age and health-related quality of life in older age. Arch Intern Med 2003, 163(20):2460-2468.